RAM MUKUNDA

Software Technology Evidence

15 mention(s) identify RAM MUKUNDA as having software/technology expertise.

Company	Filing Date	Evidence	Reason
IGC Pharma, Inc.	2008-02-08	Ram Mukunda... holds B.S. degrees in electrical engineering and mathematics and a MS in Engineering from the University of Maryland.	Has degrees in electrical engineering and mathematics, and experience in telecommunications and VOIP services, indicating programming and software engineering skills.
IGC Pharma, Inc.	2008-06-25	Mr. Mukunda holds B.S. degrees in electrical engineering and mathematics and a MS in Engineering from the University of Maryland.	Mr. Mukunda holds B.S. degrees in electrical engineering and mathematics and an MS in Engineering, indicating a strong technical background likely including programming skills.
IGC Pharma, Inc.	2011-08-01	Mr. Mukunda is an engineer by training. He holds B.S. degrees in electrical engineering and mathematics and a M.S. in Engineering from the University of Maryland.	Holds B.S. degrees in electrical engineering and mathematics and a M.S. in Engineering, indicating a strong technical background likely including programming skills.
IGC Pharma, Inc.	2011-12-09	Mr. Ram Mukunda, IGC’s founder, has served as our Executive Chairman, Chief Executive Officer and President since our inception ... He holds B.S. degrees in electrical engineering and mathematics and a M.S. in Engineering from the University of Maryland.	Mr. Mukunda has B.S. degrees in electrical engineering and mathematics and an M.S. in Engineering, indicating a strong technical background relevant to software and programming.
IGC Pharma, Inc.	2013-09-04	He holds B.S. degrees in electrical engineering and mathematics and a M.S. in Engineering from the University of Maryland. Mr. Mukunda has traveled extensively through India and has conducted business in India and China for more than 20 years. He has more than 15 years of experience managing a publicly held company, has acquired and integrated more than 18 companies, and is an engineer by training.	Holds B.S. degrees in electrical engineering and mathematics and an M.S. in Engineering; is an engineer by training with extensive technical and engineering background.
IGC Pharma, Inc.	2014-08-04	He holds B.S. degree in Electrical Engineering a B.S degree in Mathematics and a M.S. in Engineering from the University of Maryland.	Mr. Mukunda holds a B.S. degree in Electrical Engineering, a B.S degree in Mathematics and a M.S. in Engineering, indicating strong technical qualifications relevant to software and programming.
IGC Pharma, Inc.	2015-07-24	Ram Mukunda, our founder, has served as our Executive Chairman, Chief Executive Officer, and President since our inception on April 29, 2005. He holds a B.S. degree in Electrical Engineering, a B.S degree in Mathematics, and a M.S. in Engineering from the University of Maryland.	Ram Mukunda holds a B.S. degree in Electrical Engineering, a B.S degree in Mathematics, and a M.S. in Engineering, and has experience founding and leading a telecommunications company focused on VOIP services, indicating strong technical and software-related skills.
IGC Pharma, Inc.	2017-10-10	He holds a B.S. degree in Electrical Engineering, a B.S degree in Mathematics, and a M.S. in Engineering from the University of Maryland.	Mr. Mukunda holds a B.S. degree in Electrical Engineering, a B.S degree in Mathematics, and a M.S. in Engineering from the University of Maryland, indicating a strong technical background relevant to software and programming.
IGC Pharma, Inc.	2018-07-06	He holds a B.S. degree in Electrical Engineering, a B.S degree in Mathematics, and a M.S. in Engineering from the University of Maryland. He has been the chief-inventor and architect of all patent filings by the Company including the creation of the Company’s lead product Hyalolextm.	Mr. Mukunda has a B.S. degree in Electrical Engineering, a B.S degree in Mathematics, and a M.S. in Engineering, and was the chief-inventor and architect of all patent filings by the Company, indicating strong technical and software-related skills.
IGC Pharma, Inc.	2019-12-13	He earned a B.S. (1979) and a M.S. (1982) in Electrical Engineering, and a B.S (1979) in Mathematics, all from the University of Maryland. Mr. Mukunda has ... has broad science and engineering background ... He has been the chief-inventor and architect of all patent filings by the Company including the creation of the Company’s lead product Hyalolex™.	Mr. Mukunda earned a B.S. and M.S. in Electrical Engineering and a B.S. in Mathematics, has a broad science and engineering background, and was the chief-inventor and architect of all patent filings by the Company, indicating technical and programming skills.
IGC Pharma, Inc.	2020-12-08	Mr. Ram Mukunda has served as our CEO and President and in other capacities since April 29, 2005. Mr. Mukunda is responsible for general management and over the past six years has been largely responsible for the Company’s strategy and positioning in the pharmaceutical cannabinoid and medical cannabinoid industries. He has been the chief-inventor and architect of all patent filings by the Company including the creation of the Company’s lead product Hyalolex™. Since 2018 he has been focused on moving the Company into the life sciences sector and positioning the Company for FDA approved human trials using cannabinoids for the treatment of Alzheimer’s disease. Prior to IGC, from January 1990 to May 2004, Mr. Mukunda served as Founder and CEO of Startec Global Communications, that he took public in 1997 on NASDAQ. Prior to Startec, he served as Strategic Planning Advisor at Intelsat, a communications satellite services provider and prior to that worked in the bond market for a boutique firm on Wall Street. Mr. Mukunda serves as an Emeritus member on the Board of Visitors at the University of Maryland, School of Engineering. From 2001 to 2003, he was a Council Member at Harvard’s Kennedy School of Government, Belfer Center of Science and International Affairs. Mr. Mukunda is the recipient of several awards including, among others, the 2013 University of Maryland’s International Alumnus of the year award, the 2001 Distinguished Engineering Alumnus Award, the 1998 Ernst & Young, LLP’s Entrepreneur of the Year Award. He earned a B.S. (1979) and a M.S. (1982) in Electrical Engineering, and a B.S (1979) in Mathematics, all from the University of Maryland. Mr. Mukunda has traveled extensively, and managed companies in Europe and Asia. He has over 22 years of experience managing public companies and has acquired and integrated more than 20 companies. His in-depth business experience in the medical cannabinoids industry, his knowledge of U.S. capital markets, capital structuring, international joint ventures, and broad science and engineering background make him well qualified to serve as a director of our Company.	Mr. Mukunda has degrees in Electrical Engineering and Mathematics, has been the chief-inventor and architect of all patent filings by the Company, and has a broad science and engineering background, indicating technical and software-related skills.
IGC Pharma, Inc.	2021-09-15	Mr. Mukunda holds a B.S. degree in Electrical Engineering, a B.S degree in Mathematics, and a M.S. in Engineering from the University of Maryland. He has been the chief-inventor and architect of all patent filings by the Company.	Mr. Mukunda has degrees in Electrical Engineering, Mathematics, and Engineering, and has been the chief-inventor and architect of all patent filings by the Company, indicating strong technical and software-related skills.
IGC Pharma, Inc.	2022-07-25	He holds a B.S. degree in Electrical Engineering, a B.S degree in Mathematics, and a M.S. in Engineering from the University of Maryland. Mr. Mukunda has been the chief inventor and architect of all patent filings by the Company.	Holds degrees in Electrical Engineering, Mathematics, and Engineering; has been chief inventor and architect of all patent filings by the Company, indicating technical and programming-related skills.
IGC Pharma, Inc.	2023-07-26	Mr. Mukunda has been the chief inventor and architect of most of the Company’s patent filings, and the thrust into R&D and medical trials, which support the Company’s desire to bring low-cost medications that address diseases and ailments that affect humankind. He holds a B.S. degree in Electrical Engineering, a B.S degree in Mathematics, and a M.S. in Engineering from the University of Maryland.	Has a B.S. degree in Electrical Engineering and Mathematics, M.S. in Engineering, and was the chief inventor and architect of most of the Company’s patent filings, indicating technical and programming skills.
IGC Pharma, Inc.	2024-07-08	Ram Mukunda has served as Director, CEO and President since April 29, 2005. He has been the chief inventor and architect of most of the Company’s patent filings, and the thrust into R&D and medical trials, which support the Company’s desire to bring low-cost medications that address diseases and ailments that affect humankind. Prior to IGC, from January 1990 to May 2004, Mr. Mukunda served as Founder and CEO of Startec Global Communications, which he took public in 1997 on NASDAQ. Mr. Mukunda serves as an Emeritus member on the Board of Visitors at the University of Maryland, School of Engineering. Mr. Mukunda is the recipient of several awards including the 2013 University of Maryland’s International Alumnus of the year award, the 2001 Distinguished Engineering Alumnus Award, and the 1998 Ernst & Young, LLP’s Entrepreneur of the Year Award. He holds a B.S. degree in Electrical Engineering, a B.S degree in Mathematics, and a M.S. in Engineering from the University of Maryland.	Mr. Mukunda holds degrees in Electrical Engineering, Mathematics, and Engineering, and has a broad science and engineering background, including experience as the chief inventor and architect of the Company’s patent filings and R&D efforts, indicating software-related technical skills.